A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practice.
Li J, Wang Z, Zhong H, He Y, Zhang C, Niu Z, Yang S, Zhang T, Zhu L, Shu Y, Gao Y, Peng J, Song Y, Li J, Yuan Y, Zhang H, Yu G, Hua Y, Xiao J, Fu J, Zheng Y, Xue H, Luo X, Shi M, Su W, Qin S.
Li J, et al.
Oncologist. 2024 Aug 5;29(8):e1012-e1019. doi: 10.1093/oncolo/oyae073.
Oncologist. 2024.
PMID: 38642091
Free PMC article.
Clinical Trial.